Amdocs (DOX) Gains from Sales and Divestitures (2016 - 2025)
Amdocs (DOX) has 10 years of Gains from Sales and Divestitures data on record, last reported at $932000.0 in Q3 2025.
- On a quarterly basis, Gains from Sales and Divestitures rose 9.01% to $932000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $932000.0, a 9.01% increase, with the full-year FY2025 number at $932000.0, up 9.01% from a year prior.
- Gains from Sales and Divestitures reached $932000.0 in Q3 2025 per DOX's latest filing, up from $855000.0 in the prior quarter.
- Over the last five years, Gains from Sales and Divestitures for DOX hit a ceiling of $932000.0 in Q3 2025 and a floor of $146000.0 in Q3 2023.
- A 3-year average of $644333.3 and a median of $855000.0 in 2024 define the central range for Gains from Sales and Divestitures.
- Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 485.62% in 2024, then increased 9.01% in 2025.
- Tracing DOX's Gains from Sales and Divestitures over 3 years: stood at $146000.0 in 2023, then surged by 485.62% to $855000.0 in 2024, then grew by 9.01% to $932000.0 in 2025.
- Business Quant data shows Gains from Sales and Divestitures for DOX at $932000.0 in Q3 2025, $855000.0 in Q3 2024, and $146000.0 in Q3 2023.